Join
Live feed
·
INSIDERFilingvia Quantisnow
Adamas Pharmaceuticals, Inc. logo

SEC Form 4: Shreedhar Vijay was granted 18,750 shares, closing all direct ownership in the company

ByQuantisnow·Wall Street's wire, on your screen.
ADMS· Adamas Pharmaceuticals, Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ADMS (Adamas Pharmaceuticals, Inc.) and more on Quantisnow.